05:14 PM EDT, 06/30/2025 (MT Newswires) -- AdaptHealth ( AHCO ) said late Monday it completed the sale of certain infusion assets within its Wellness at Home segment to a third party.

The deal, finalized earlier this month, did not have its financial terms disclosed.

The company said it used proceeds from the sale, along with other funds, to prepay $65 million on its outstanding term loan. That follows a $70 million prepayment in May, funded primarily by the sale of incontinence assets.

The divested infusion assets generated about $52 million in annual revenue and $5 million in annual adjusted earnings before interest, taxes, depreciation, and amortization. AdaptHealth ( AHCO ) expects to pay about $30 million in cash taxes on gains from the sale.

As a result, the company revised its full-year 2025 guidance to revenue between $3.15 billion and $3.29 billion, adjusted EBITDA of $662 million to $702 million, and free cash flow of $170 million to $190 million.

Analysts polled by FactSet expect revenue of $3.25 billion.